Clinical Trials
2 trialsNCT05372614 2026-05-18
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
National Cancer Institute (NCI)
Phase 1 Suspended
NCT04502602 2026-05-11
iNNOVATE
Virginia Commonwealth University
Phase 1 Active not recruiting